title: Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study.
abstract: OBJECTIVE
  To study management of hypertension in the elderly in a large population-based study and to evaluate the prevalence of hypertension and factors related to awareness, treatment, and control.
  
  
  METHODS
  The Three City study, a population-based study among 9693 non-institutionalized individuals aged 65 years and over.
  
  
  METHODS
  Blood pressure was measured with an automated electronic device, and treatment assessed, during home interview. Hypertension was defined by a mean blood pressure of two measurements superior to or equal to 160/95 mmHg and/or the intake of antihypertensive medications.
  
  
  RESULTS
  In the final working sample of 9090 people, 62% were hypertensive. More than two-thirds were aware of their hypertension and 81% were treated with antihypertensive drugs. Among 4573 treated hypertensive participants, 35% had a blood pressure over 160/95 mmHg and 69% over 140/90 mmHg. Women were more frequently aware of their hypertension, more frequently treated, and more frequently controlled than men. A history of cardiovascular disease, high body mass index, diabetes and high frequency of visits to the general practitioner were related to higher percentages of awareness and treatment. Among treated hypertensive patients, those with a history of cardiovascular events or who visited their general practitioner more often or who more often had their blood pressure measured were more frequently controlled. Awareness was strongly associated with treatment, but was inversely related to control of hypertension among treated hypertensive patients.
  
  
  CONCLUSIONS
  Management of hypertension, and particularly its control among treated hypertensive patients, needs to be improved in people aged 65 years and over.
authors.affiliation: INSERM, U708, Paris, France.
authors.forename: Pauline
authors.initials: P
authors.lastname: Brindel
authors.forename: Oliver
authors.initials: O
authors.lastname: Hanon
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Dartigues
authors.forename: Karen
authors.initials: K
authors.lastname: Ritchie
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Lacombe
authors.forename: Pierre
authors.initials: P
authors.lastname: Ducimetière
authors.forename: Annick
authors.initials: A
authors.lastname: Alpérovitch
authors.forename: Christophe
authors.initials: C
authors.lastname: Tzourio
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D003627:Data Interpretation, Statistical; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000503:physiopathology; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology* / Q000503:physiopathology; D008297:Male; D009765:Obesity / Q000453:epidemiology / Q000503:physiopathology; D009819:Office Visits / Q000706:statistics & numerical data; D015995:Prevalence
chemical_list: D000959:Antihypertensive Agents